Role of Flavonoids in Combating Hyperuricemia
DOI:
https://doi.org/10.25081/imrj.2023.v13.8731Keywords:
Hyperuricemia, Flavonoids, Xanthine oxidase, Hyperuricemic mice, Urate transportersAbstract
Individuals tend to have an increased blood uric acid level at a younger age due to their dietary choices and lifestyle, which can lead to major health concerns such as hyperuricemia, gout, cardiovascular disease, nephropathy, and inflammation. Flavonoids have been proven to have strong inhibitory action against xanthine oxidase and be able to lower serum uric acid levels, levels of adenosine deaminase, gene expressions of renal glucose transporter type 9 (mGLUT9) and uric acid transporter 1 (mURAT1), along with increased expression of organic anion transporters (mOAT1 and mOAT3) and organic cation transporters (mOCT1 and mOCT2). Furthermore, flavonoids enhanced renal function and antioxidant activity in hyperuricemic rats. In hyperuricemic mice, genistein reduced renal fibrosis by inhibiting the JAK2/STAT3 and Wnt/β-catenin signaling pathways. Overall, this review reveals that the flavonoids have substantial anti-hyperuricemia and associated disease potential and may be utilized as natural supplements for the treatment of Uric acid-related illnesses.
Downloads
References
Borges, F., Fernandes, E., & Roleira, F. (2002). Progress towards the discovery of xanthine oxidase inhibitors. Current Medicinal Chemistry, 9(2), 195-217. https://doi.org/10.2174/0929867023371229
Dalbeth, N., Choi, H. K., Joosten, L. A. B., Khanna, P. P., Matsuo, H., Perez-Ruiz, F., & Stamp, L. K. (2019). Gout. Nature Reviews Disease Primers, 5, 69. https://doi.org/10.1038/s41572-019-0115-y
Dalbeth, N., Stamp, L. K., & Merriman, T. R. (2017). The genetics of gout: Towards personalised medicine? BMC Medicine, 15, 108. https://doi.org/10.1186/s12916-017-0878-5
Dwyer, J. T., & Peterson, J. (2013). J. Tea and flavonoids: Where we are, where to go next. The American Journal of Clinical Nutrition, 98(S6), 1611S-1618S. https://doi.org/10.3945/ajcn.113.059584
Fang, R., Uchiyama, R., Sakai, S., Hara, H., Tsutsui, H., Suda, T., Mitsuyama, M., Kawamura, I., & Tsuchiya, K. (2019). ASC and NLRP3 maintain innate immune homeostasis in the airway through an inflammasome-independent mechanism. Mucosal Immunology, 12, 1092-1103. https://doi.org/10.1038/s41385-019-0181-1
Feng, S., Wu, S., Xie, F., Yang, C. S., & Shao, P. (2022). Natural compounds lower uric acid levels and hyperuricemia: Molecular mechanisms and prospective. Trends in Food Science & Technology, 123, 87-102. https://doi.org/10.1016/j.tifs.2022.03.002
Ganeshpurkar, A., & Saluja, A. K. (2017). The pharmacological potential of rutin. Saudi Pharmaceutical Journal, 25(2), 149-164. https://doi.org/10.1016/j.jsps.2016.04.025
Horiuchi, H., Ota, M., Nishimura, S.-I., Kaneko, H., Kasahara, Y., Ohta, T., & Komoriya, K. (2000). Allopurinol induces renal toxicity by impairing pyrimidine metabolism in mice. Life Sciences, 66(21), 2051-2070. https://doi.org/10.1016/s0024-3205(00)00532-4
Kutryb-Zajac, B., Mierzejewska, P., Slominska, E. M., & Smolenski, R. T. (2020). Therapeutic perspectives of adenosine deaminase inhibition in cardiovascular diseases. Molecules, 25(20), 4652. https://doi.org/10.3390/molecules25204652
Liu, T., Gao, H., Zhang, Y., Wang, S., Lu, M., Dai, X., Liu, Y., Shi, H., Xu, T., Yin, J., Gao, S., Wang, L., & Zhang, D. (2022, November 21). Apigenin ameliorates hyperuricemia and renal injury through regulation of uric acid metabolism and Jak2/Stat3 signaling pathway. Pharmaceuticals, 15(11), 1442. https://doi.org/10.3390/ph15111442
Melzig, M. F. (1996). Inhibition of adenosine deaminase activity of aortic endothelial cells by selected flavonoids. Planta Medica, 62(1), 20-21. https://doi.org/10.1055/s-2006-957788
Mo, S.-F., Zhou, F., Lv, Y.-Z., Hu, Q.-H., Zhang, D.-M., & Kong, L.-D. (2007). Hypouricemic action of selected flavonoids in mice: Structure–activity relationships. Biological and Pharmaceutical Bulletin, 30(8), 1551-1556. https://doi.org/10.1248/bpb.30.1551
Nutmakul, T. (2022). A review on benefits of quercetin in hyperuricemia and gouty arthritis. Saudi Pharmaceutical Journal, 30(7), 918-926. https://doi.org/10.1016/j.jsps.2022.04.013
Omar, B., Mohamed, N., Rahim, R. A., & Wahab, H. A. (2007). Natural Flavonoids for the treatment of hyperuricemia, Molecular Docking studies. In R. Magjarevic & J. H. Nagel (Eds.), World Congress on Medical Physics and Biomedical Engineering (Vol. 14, pp. 178-182) Berlin, Heidelberg: Springer. https://doi.org/10.1007/978-3-540-36841-0_53
Ozyel, B., Le Gall, G., Needs, P. W., & Kroon, P. A. (2021). Anti‐inflammatory effects of quercetin on high‐glucose and pro‐inflammatory cytokine challenged vascular endothelial cell metabolism. Molecular Nutrition and Food Research, 65(6), e2000777. https://doi.org/10.1002/mnfr.202000777
Panche, A. N., Diwan, A. D., & Chandra, S. R. (2016). Flavonoids: An overview. Journal of Nutritional Science, 5, e47. https://doi.org/10.1017/jns.2016.41
Pavese, J. M., Farmer, R. L., & Bergan, R. C. (2010). Inhibition of cancer cell invasion and metastasis by genistein. Cancer Metastasis Reviews, 29, 465-482. https://doi.org/10.1007/s10555-010-9238-z
Qian, X., Wang, X., Luo, J., Liu, Y., Pang, J., Zhang, H., Xu, Z., Xie, J., Jiang, X., & Ling, W. (2019). Hypouricemic and nephroprotective roles of anthocyanins in hyperuricemic mice. Food and Function, 10(2), 867-878. https://doi.org/10.1039/c8fo02124d
Rehman, K., Ali, M. B., & Akash, M. S. H. (2019). Genistein enhances the secretion of glucagon-like peptide-1 (GLP-1) via downregulation of inflammatory responses. Biomedicine & Pharmacotherapy, 112, 108670. https://doi.org/10.1016/j.biopha.2019.108670
Rundles, R. W., Metz, E. N., & Silberman, H. R. (1966). Allopurinol in the treatment of gout. Annals of Internal Medicine, 64(2), 229-258. https://doi.org/10.7326/0003-4819-64-2-229
Shibata, T., Nakashima, F., Honda, K., Lu, Y.-J., Kondo, T., Ushida, Y., Aizawa, K., Suganuma, H., Oe, S., Tanaka, H., Takahashi, T., & Uchida, K. (2014). Toll-like receptors as a target of food-derived anti-inflammatory compounds. Journal of Biological Chemistry, 289(47), 32757-32772. https://doi.org/10.1074/jbc.M114.585901
Wang, Z., Hu, W., Lu, C., Ma, Z., Jiang, S., Gu, C., Acuña-Castroviejo, D., & Yang, Y. (2018). Targeting NLRP3 (nucleotide-binding domain, leucine-rich–containing family, pyrin domain–containing-3) inflammasome in cardiovascular disorders. Arteriosclerosis, Thrombosis, and Vascular Biology, 38, 2765-2779. https://doi.org/10.1161/ATVBAHA.118.311916
Wei-Yun, B., & Cailin, Z. (2021). Genistein ameliorates hyperuricemia-associated nephropathy in hyperuricemic mice. Food and Agricultural Immunology, 32(1), 778-797. https://doi.org/10.1080/09540105.2021.1996540
Wu, D., Chen, R., Zhang, W., Lai, X., Sun, L., Li, Q., Zhang, Z., Cao, J., Wen, S., Lai, Z., Li, Z., Cao, F., & Sun, S. (2022). Tea and its components reduce the production of uric acid by inhibiting xanthine oxidase. Food & Nutrition Research, 66. https://doi.org/10.29219/fnr.v66.8239
Wu, H., Wang, Y., Huang, J., Li, Y., Lin, Z., & Zhang, B. (2023). Rutin ameliorates gout via reducing XOD activity, inhibiting ROS production and NLRP3 inflammasome activation in quail. Biomedicine and Pharmacotherapy, 158, 114175. https://doi.org/10.1016/j.biopha.2022.114175
Published
How to Cite
Issue
Section
Copyright (c) 2023 Basavaraj Gorrjanal, B. M. Monika, R. Mythreyi, Karthikeyan Muthusamy, Karthikeyan Murugesan, Anjuna Radhakrishnan, S. Jagannathan, Boojhana Elango, Kanthesh M. Basalingappa, Maghimaa Mathanmohun
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.